Page last updated: 2024-08-21

quinazolines and Connective Tissue Neoplasms

quinazolines has been researched along with Connective Tissue Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beuschel, SL; Hillegass, JM; MacPherson, MB; Macura, SL; Miller, JM; Mossman, BT; Perkins, TN; Sayan, M; Shukla, A; Thompson, JK1

Other Studies

1 other study(ies) available for quinazolines and Connective Tissue Neoplasms

ArticleYear
Extracellular signal-regulated kinase 5 and cyclic AMP response element binding protein are novel pathways inhibited by vandetanib (ZD6474) and doxorubicin in mesotheliomas.
    American journal of respiratory cell and molecular biology, 2014, Volume: 51, Issue:5

    Topics: Antibiotics, Antineoplastic; Cell Line, Tumor; Cell Survival; Cyclic AMP Response Element-Binding Protein; Doxorubicin; Drug Synergism; Humans; MAP Kinase Signaling System; Mesothelioma; Mitogen-Activated Protein Kinase 7; Neoplasms, Connective Tissue; Phosphorylation; Piperidines; Quinazolines; RNA, Small Interfering; Sarcoma

2014